Novartis CEO Vas Narasimhan lost no time to refocus the company’s R&D engine on finding scientific solutions for the coronavirus crisis, helped set up emergency health programs and made Novartis the first company to commit to keeping relevant and essential generic medicines cost-stable. Nevertheless, he is warning of a hidden epidemic.

Published on 21/01/2021